0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Multi-Cancer Detection Blood Test Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-14Y18024
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Multi Cancer Detection Blood Test Market Research Report 2024
BUY CHAPTERS

Global Multi-Cancer Detection Blood Test Market Research Report 2025

Code: QYRE-Auto-14Y18024
Report
May 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Multi-Cancer Detection Blood Test Market

The global market for Multi-Cancer Detection Blood Test was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The Multi-Cancer Detection Blood Test, also known as a liquid biopsy or pan-cancer test, is a type of medical test that aims to detect multiple types of cancer in the body using a blood sample. Unlike traditional cancer screenings that focus on specific cancer types, this test is designed to provide a more comprehensive assessment by detecting various cancer-related biomarkers or genetic alterations present in the bloodstream.
The Multi-Cancer Detection Blood Test holds promise for early cancer detection, as it can potentially identify cancers at an earlier stage when treatment options are more effective and outcomes are better. It may also aid in monitoring cancer patients during treatment and post-treatment to detect recurrence or treatment response.
North American market for Multi-Cancer Detection Blood Test is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Multi-Cancer Detection Blood Test is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Multi-Cancer Detection Blood Test include Galleri, Amadix, Burning Rock, Exact Sciences, Freenome, AnchorDx, Guardant Health, Foundation Medicine, GENECAST, Coyne Medical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Multi-Cancer Detection Blood Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multi-Cancer Detection Blood Test.
The Multi-Cancer Detection Blood Test market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Multi-Cancer Detection Blood Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multi-Cancer Detection Blood Test manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Multi-Cancer Detection Blood Test Market Report

Report Metric Details
Report Name Multi-Cancer Detection Blood Test Market
Segment by Type
  • ctDNA-Based Tests
  • Protein Biomarker-Based Tests
  • Methylation-Based Tests
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Galleri, Amadix, Burning Rock, Exact Sciences, Freenome, AnchorDx, Guardant Health, Foundation Medicine, GENECAST, Coyne Medical, Laboratory for Advanced Medicine, Singlera Genomics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Multi-Cancer Detection Blood Test manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Multi-Cancer Detection Blood Test in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Multi-Cancer Detection Blood Test Market report?

Ans: The main players in the Multi-Cancer Detection Blood Test Market are Galleri, Amadix, Burning Rock, Exact Sciences, Freenome, AnchorDx, Guardant Health, Foundation Medicine, GENECAST, Coyne Medical, Laboratory for Advanced Medicine, Singlera Genomics

What are the Application segmentation covered in the Multi-Cancer Detection Blood Test Market report?

Ans: The Applications covered in the Multi-Cancer Detection Blood Test Market report are Hospitals, Diagnostic Laboratories, Others

What are the Type segmentation covered in the Multi-Cancer Detection Blood Test Market report?

Ans: The Types covered in the Multi-Cancer Detection Blood Test Market report are ctDNA-Based Tests, Protein Biomarker-Based Tests, Methylation-Based Tests, Others

Recommended Reports

Blood Testing Devices

Cancer & Biomarkers

Liquid Biopsy & Detection

1 Multi-Cancer Detection Blood Test Market Overview
1.1 Product Definition
1.2 Multi-Cancer Detection Blood Test by Type
1.2.1 Global Multi-Cancer Detection Blood Test Market Value Comparison by Type (2024 VS 2031)
1.2.2 ctDNA-Based Tests
1.2.3 Protein Biomarker-Based Tests
1.2.4 Methylation-Based Tests
1.2.5 Others
1.3 Multi-Cancer Detection Blood Test by Application
1.3.1 Global Multi-Cancer Detection Blood Test Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Global Multi-Cancer Detection Blood Test Market Size Estimates and Forecasts
1.4.1 Global Multi-Cancer Detection Blood Test Revenue 2020-2031
1.4.2 Global Multi-Cancer Detection Blood Test Sales 2020-2031
1.4.3 Global Multi-Cancer Detection Blood Test Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Multi-Cancer Detection Blood Test Market Competition by Manufacturers
2.1 Global Multi-Cancer Detection Blood Test Sales Market Share by Manufacturers (2020-2025)
2.2 Global Multi-Cancer Detection Blood Test Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Multi-Cancer Detection Blood Test Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Multi-Cancer Detection Blood Test, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Multi-Cancer Detection Blood Test, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Multi-Cancer Detection Blood Test, Product Type & Application
2.7 Global Key Manufacturers of Multi-Cancer Detection Blood Test, Date of Enter into This Industry
2.8 Global Multi-Cancer Detection Blood Test Market Competitive Situation and Trends
2.8.1 Global Multi-Cancer Detection Blood Test Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Multi-Cancer Detection Blood Test Players Market Share by Revenue
2.8.3 Global Multi-Cancer Detection Blood Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Multi-Cancer Detection Blood Test Market Scenario by Region
3.1 Global Multi-Cancer Detection Blood Test Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Multi-Cancer Detection Blood Test Sales by Region: 2020-2031
3.2.1 Global Multi-Cancer Detection Blood Test Sales by Region: 2020-2025
3.2.2 Global Multi-Cancer Detection Blood Test Sales by Region: 2026-2031
3.3 Global Multi-Cancer Detection Blood Test Revenue by Region: 2020-2031
3.3.1 Global Multi-Cancer Detection Blood Test Revenue by Region: 2020-2025
3.3.2 Global Multi-Cancer Detection Blood Test Revenue by Region: 2026-2031
3.4 North America Multi-Cancer Detection Blood Test Market Facts & Figures by Country
3.4.1 North America Multi-Cancer Detection Blood Test Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Multi-Cancer Detection Blood Test Sales by Country (2020-2031)
3.4.3 North America Multi-Cancer Detection Blood Test Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Multi-Cancer Detection Blood Test Market Facts & Figures by Country
3.5.1 Europe Multi-Cancer Detection Blood Test Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Multi-Cancer Detection Blood Test Sales by Country (2020-2031)
3.5.3 Europe Multi-Cancer Detection Blood Test Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Multi-Cancer Detection Blood Test Market Facts & Figures by Region
3.6.1 Asia Pacific Multi-Cancer Detection Blood Test Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Multi-Cancer Detection Blood Test Sales by Region (2020-2031)
3.6.3 Asia Pacific Multi-Cancer Detection Blood Test Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Multi-Cancer Detection Blood Test Market Facts & Figures by Country
3.7.1 Latin America Multi-Cancer Detection Blood Test Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Multi-Cancer Detection Blood Test Sales by Country (2020-2031)
3.7.3 Latin America Multi-Cancer Detection Blood Test Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Multi-Cancer Detection Blood Test Market Facts & Figures by Country
3.8.1 Middle East and Africa Multi-Cancer Detection Blood Test Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Multi-Cancer Detection Blood Test Sales by Country (2020-2031)
3.8.3 Middle East and Africa Multi-Cancer Detection Blood Test Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Multi-Cancer Detection Blood Test Sales by Type (2020-2031)
4.1.1 Global Multi-Cancer Detection Blood Test Sales by Type (2020-2025)
4.1.2 Global Multi-Cancer Detection Blood Test Sales by Type (2026-2031)
4.1.3 Global Multi-Cancer Detection Blood Test Sales Market Share by Type (2020-2031)
4.2 Global Multi-Cancer Detection Blood Test Revenue by Type (2020-2031)
4.2.1 Global Multi-Cancer Detection Blood Test Revenue by Type (2020-2025)
4.2.2 Global Multi-Cancer Detection Blood Test Revenue by Type (2026-2031)
4.2.3 Global Multi-Cancer Detection Blood Test Revenue Market Share by Type (2020-2031)
4.3 Global Multi-Cancer Detection Blood Test Price by Type (2020-2031)
5 Segment by Application
5.1 Global Multi-Cancer Detection Blood Test Sales by Application (2020-2031)
5.1.1 Global Multi-Cancer Detection Blood Test Sales by Application (2020-2025)
5.1.2 Global Multi-Cancer Detection Blood Test Sales by Application (2026-2031)
5.1.3 Global Multi-Cancer Detection Blood Test Sales Market Share by Application (2020-2031)
5.2 Global Multi-Cancer Detection Blood Test Revenue by Application (2020-2031)
5.2.1 Global Multi-Cancer Detection Blood Test Revenue by Application (2020-2025)
5.2.2 Global Multi-Cancer Detection Blood Test Revenue by Application (2026-2031)
5.2.3 Global Multi-Cancer Detection Blood Test Revenue Market Share by Application (2020-2031)
5.3 Global Multi-Cancer Detection Blood Test Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Galleri
6.1.1 Galleri Company Information
6.1.2 Galleri Description and Business Overview
6.1.3 Galleri Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Galleri Multi-Cancer Detection Blood Test Product Portfolio
6.1.5 Galleri Recent Developments/Updates
6.2 Amadix
6.2.1 Amadix Company Information
6.2.2 Amadix Description and Business Overview
6.2.3 Amadix Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Amadix Multi-Cancer Detection Blood Test Product Portfolio
6.2.5 Amadix Recent Developments/Updates
6.3 Burning Rock
6.3.1 Burning Rock Company Information
6.3.2 Burning Rock Description and Business Overview
6.3.3 Burning Rock Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Burning Rock Multi-Cancer Detection Blood Test Product Portfolio
6.3.5 Burning Rock Recent Developments/Updates
6.4 Exact Sciences
6.4.1 Exact Sciences Company Information
6.4.2 Exact Sciences Description and Business Overview
6.4.3 Exact Sciences Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Exact Sciences Multi-Cancer Detection Blood Test Product Portfolio
6.4.5 Exact Sciences Recent Developments/Updates
6.5 Freenome
6.5.1 Freenome Company Information
6.5.2 Freenome Description and Business Overview
6.5.3 Freenome Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Freenome Multi-Cancer Detection Blood Test Product Portfolio
6.5.5 Freenome Recent Developments/Updates
6.6 AnchorDx
6.6.1 AnchorDx Company Information
6.6.2 AnchorDx Description and Business Overview
6.6.3 AnchorDx Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AnchorDx Multi-Cancer Detection Blood Test Product Portfolio
6.6.5 AnchorDx Recent Developments/Updates
6.7 Guardant Health
6.7.1 Guardant Health Company Information
6.7.2 Guardant Health Description and Business Overview
6.7.3 Guardant Health Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Guardant Health Multi-Cancer Detection Blood Test Product Portfolio
6.7.5 Guardant Health Recent Developments/Updates
6.8 Foundation Medicine
6.8.1 Foundation Medicine Company Information
6.8.2 Foundation Medicine Description and Business Overview
6.8.3 Foundation Medicine Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Foundation Medicine Multi-Cancer Detection Blood Test Product Portfolio
6.8.5 Foundation Medicine Recent Developments/Updates
6.9 GENECAST
6.9.1 GENECAST Company Information
6.9.2 GENECAST Description and Business Overview
6.9.3 GENECAST Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GENECAST Multi-Cancer Detection Blood Test Product Portfolio
6.9.5 GENECAST Recent Developments/Updates
6.10 Coyne Medical
6.10.1 Coyne Medical Company Information
6.10.2 Coyne Medical Description and Business Overview
6.10.3 Coyne Medical Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Coyne Medical Multi-Cancer Detection Blood Test Product Portfolio
6.10.5 Coyne Medical Recent Developments/Updates
6.11 Laboratory for Advanced Medicine
6.11.1 Laboratory for Advanced Medicine Company Information
6.11.2 Laboratory for Advanced Medicine Description and Business Overview
6.11.3 Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Product Portfolio
6.11.5 Laboratory for Advanced Medicine Recent Developments/Updates
6.12 Singlera Genomics
6.12.1 Singlera Genomics Company Information
6.12.2 Singlera Genomics Description and Business Overview
6.12.3 Singlera Genomics Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Singlera Genomics Multi-Cancer Detection Blood Test Product Portfolio
6.12.5 Singlera Genomics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Multi-Cancer Detection Blood Test Industry Chain Analysis
7.2 Multi-Cancer Detection Blood Test Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Multi-Cancer Detection Blood Test Production Mode & Process Analysis
7.4 Multi-Cancer Detection Blood Test Sales and Marketing
7.4.1 Multi-Cancer Detection Blood Test Sales Channels
7.4.2 Multi-Cancer Detection Blood Test Distributors
7.5 Multi-Cancer Detection Blood Test Customer Analysis
8 Multi-Cancer Detection Blood Test Market Dynamics
8.1 Multi-Cancer Detection Blood Test Industry Trends
8.2 Multi-Cancer Detection Blood Test Market Drivers
8.3 Multi-Cancer Detection Blood Test Market Challenges
8.4 Multi-Cancer Detection Blood Test Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Multi-Cancer Detection Blood Test Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Multi-Cancer Detection Blood Test Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Multi-Cancer Detection Blood Test Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Multi-Cancer Detection Blood Test Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Multi-Cancer Detection Blood Test Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Multi-Cancer Detection Blood Test Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Multi-Cancer Detection Blood Test Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Multi-Cancer Detection Blood Test Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Multi-Cancer Detection Blood Test, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Multi-Cancer Detection Blood Test, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Multi-Cancer Detection Blood Test, Product Type & Application
 Table 12. Global Key Manufacturers of Multi-Cancer Detection Blood Test, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Multi-Cancer Detection Blood Test by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multi-Cancer Detection Blood Test as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Multi-Cancer Detection Blood Test Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Multi-Cancer Detection Blood Test Sales by Region (2020-2025) & (K Units)
 Table 18. Global Multi-Cancer Detection Blood Test Sales Market Share by Region (2020-2025)
 Table 19. Global Multi-Cancer Detection Blood Test Sales by Region (2026-2031) & (K Units)
 Table 20. Global Multi-Cancer Detection Blood Test Sales Market Share by Region (2026-2031)
 Table 21. Global Multi-Cancer Detection Blood Test Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Multi-Cancer Detection Blood Test Revenue Market Share by Region (2020-2025)
 Table 23. Global Multi-Cancer Detection Blood Test Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Multi-Cancer Detection Blood Test Revenue Market Share by Region (2026-2031)
 Table 25. North America Multi-Cancer Detection Blood Test Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Multi-Cancer Detection Blood Test Sales by Country (2020-2025) & (K Units)
 Table 27. North America Multi-Cancer Detection Blood Test Sales by Country (2026-2031) & (K Units)
 Table 28. North America Multi-Cancer Detection Blood Test Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Multi-Cancer Detection Blood Test Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Multi-Cancer Detection Blood Test Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Multi-Cancer Detection Blood Test Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Multi-Cancer Detection Blood Test Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Multi-Cancer Detection Blood Test Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Multi-Cancer Detection Blood Test Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Multi-Cancer Detection Blood Test Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Multi-Cancer Detection Blood Test Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Multi-Cancer Detection Blood Test Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Multi-Cancer Detection Blood Test Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Multi-Cancer Detection Blood Test Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Multi-Cancer Detection Blood Test Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Multi-Cancer Detection Blood Test Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Multi-Cancer Detection Blood Test Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Multi-Cancer Detection Blood Test Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Multi-Cancer Detection Blood Test Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Multi-Cancer Detection Blood Test Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Multi-Cancer Detection Blood Test Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Multi-Cancer Detection Blood Test Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Multi-Cancer Detection Blood Test Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Multi-Cancer Detection Blood Test Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Multi-Cancer Detection Blood Test Sales (K Units) by Type (2020-2025)
 Table 51. Global Multi-Cancer Detection Blood Test Sales (K Units) by Type (2026-2031)
 Table 52. Global Multi-Cancer Detection Blood Test Sales Market Share by Type (2020-2025)
 Table 53. Global Multi-Cancer Detection Blood Test Sales Market Share by Type (2026-2031)
 Table 54. Global Multi-Cancer Detection Blood Test Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Multi-Cancer Detection Blood Test Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Multi-Cancer Detection Blood Test Revenue Market Share by Type (2020-2025)
 Table 57. Global Multi-Cancer Detection Blood Test Revenue Market Share by Type (2026-2031)
 Table 58. Global Multi-Cancer Detection Blood Test Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Multi-Cancer Detection Blood Test Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Multi-Cancer Detection Blood Test Sales (K Units) by Application (2020-2025)
 Table 61. Global Multi-Cancer Detection Blood Test Sales (K Units) by Application (2026-2031)
 Table 62. Global Multi-Cancer Detection Blood Test Sales Market Share by Application (2020-2025)
 Table 63. Global Multi-Cancer Detection Blood Test Sales Market Share by Application (2026-2031)
 Table 64. Global Multi-Cancer Detection Blood Test Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Multi-Cancer Detection Blood Test Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Multi-Cancer Detection Blood Test Revenue Market Share by Application (2020-2025)
 Table 67. Global Multi-Cancer Detection Blood Test Revenue Market Share by Application (2026-2031)
 Table 68. Global Multi-Cancer Detection Blood Test Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Multi-Cancer Detection Blood Test Price (US$/Unit) by Application (2026-2031)
 Table 70. Galleri Company Information
 Table 71. Galleri Description and Business Overview
 Table 72. Galleri Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Galleri Multi-Cancer Detection Blood Test Product
 Table 74. Galleri Recent Developments/Updates
 Table 75. Amadix Company Information
 Table 76. Amadix Description and Business Overview
 Table 77. Amadix Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Amadix Multi-Cancer Detection Blood Test Product
 Table 79. Amadix Recent Developments/Updates
 Table 80. Burning Rock Company Information
 Table 81. Burning Rock Description and Business Overview
 Table 82. Burning Rock Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Burning Rock Multi-Cancer Detection Blood Test Product
 Table 84. Burning Rock Recent Developments/Updates
 Table 85. Exact Sciences Company Information
 Table 86. Exact Sciences Description and Business Overview
 Table 87. Exact Sciences Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Exact Sciences Multi-Cancer Detection Blood Test Product
 Table 89. Exact Sciences Recent Developments/Updates
 Table 90. Freenome Company Information
 Table 91. Freenome Description and Business Overview
 Table 92. Freenome Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Freenome Multi-Cancer Detection Blood Test Product
 Table 94. Freenome Recent Developments/Updates
 Table 95. AnchorDx Company Information
 Table 96. AnchorDx Description and Business Overview
 Table 97. AnchorDx Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. AnchorDx Multi-Cancer Detection Blood Test Product
 Table 99. AnchorDx Recent Developments/Updates
 Table 100. Guardant Health Company Information
 Table 101. Guardant Health Description and Business Overview
 Table 102. Guardant Health Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Guardant Health Multi-Cancer Detection Blood Test Product
 Table 104. Guardant Health Recent Developments/Updates
 Table 105. Foundation Medicine Company Information
 Table 106. Foundation Medicine Description and Business Overview
 Table 107. Foundation Medicine Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Foundation Medicine Multi-Cancer Detection Blood Test Product
 Table 109. Foundation Medicine Recent Developments/Updates
 Table 110. GENECAST Company Information
 Table 111. GENECAST Description and Business Overview
 Table 112. GENECAST Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. GENECAST Multi-Cancer Detection Blood Test Product
 Table 114. GENECAST Recent Developments/Updates
 Table 115. Coyne Medical Company Information
 Table 116. Coyne Medical Description and Business Overview
 Table 117. Coyne Medical Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Coyne Medical Multi-Cancer Detection Blood Test Product
 Table 119. Coyne Medical Recent Developments/Updates
 Table 120. Laboratory for Advanced Medicine Company Information
 Table 121. Laboratory for Advanced Medicine Description and Business Overview
 Table 122. Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Product
 Table 124. Laboratory for Advanced Medicine Recent Developments/Updates
 Table 125. Singlera Genomics Company Information
 Table 126. Singlera Genomics Description and Business Overview
 Table 127. Singlera Genomics Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Singlera Genomics Multi-Cancer Detection Blood Test Product
 Table 129. Singlera Genomics Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Multi-Cancer Detection Blood Test Distributors List
 Table 133. Multi-Cancer Detection Blood Test Customers List
 Table 134. Multi-Cancer Detection Blood Test Market Trends
 Table 135. Multi-Cancer Detection Blood Test Market Drivers
 Table 136. Multi-Cancer Detection Blood Test Market Challenges
 Table 137. Multi-Cancer Detection Blood Test Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Multi-Cancer Detection Blood Test
 Figure 2. Global Multi-Cancer Detection Blood Test Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Multi-Cancer Detection Blood Test Market Share by Type: 2024 & 2031
 Figure 4. ctDNA-Based Tests Product Picture
 Figure 5. Protein Biomarker-Based Tests Product Picture
 Figure 6. Methylation-Based Tests Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Multi-Cancer Detection Blood Test Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Multi-Cancer Detection Blood Test Market Share by Application: 2024 & 2031
 Figure 10. Hospitals
 Figure 11. Diagnostic Laboratories
 Figure 12. Others
 Figure 13. Global Multi-Cancer Detection Blood Test Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Multi-Cancer Detection Blood Test Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Multi-Cancer Detection Blood Test Sales (2020-2031) & (K Units)
 Figure 16. Global Multi-Cancer Detection Blood Test Average Price (US$/Unit) & (2020-2031)
 Figure 17. Multi-Cancer Detection Blood Test Report Years Considered
 Figure 18. Multi-Cancer Detection Blood Test Sales Share by Manufacturers in 2024
 Figure 19. Global Multi-Cancer Detection Blood Test Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Multi-Cancer Detection Blood Test Players: Market Share by Revenue in Multi-Cancer Detection Blood Test in 2024
 Figure 21. Multi-Cancer Detection Blood Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Multi-Cancer Detection Blood Test Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Multi-Cancer Detection Blood Test Sales Market Share by Country (2020-2031)
 Figure 24. North America Multi-Cancer Detection Blood Test Revenue Market Share by Country (2020-2031)
 Figure 25. United States Multi-Cancer Detection Blood Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Multi-Cancer Detection Blood Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Multi-Cancer Detection Blood Test Sales Market Share by Country (2020-2031)
 Figure 28. Europe Multi-Cancer Detection Blood Test Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Multi-Cancer Detection Blood Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Multi-Cancer Detection Blood Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Multi-Cancer Detection Blood Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Multi-Cancer Detection Blood Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Multi-Cancer Detection Blood Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Multi-Cancer Detection Blood Test Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Multi-Cancer Detection Blood Test Revenue Market Share by Region (2020-2031)
 Figure 36. China Multi-Cancer Detection Blood Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Multi-Cancer Detection Blood Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Multi-Cancer Detection Blood Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Multi-Cancer Detection Blood Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Multi-Cancer Detection Blood Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Multi-Cancer Detection Blood Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Multi-Cancer Detection Blood Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Multi-Cancer Detection Blood Test Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Multi-Cancer Detection Blood Test Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Multi-Cancer Detection Blood Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Multi-Cancer Detection Blood Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Multi-Cancer Detection Blood Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Multi-Cancer Detection Blood Test Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Multi-Cancer Detection Blood Test Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Multi-Cancer Detection Blood Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Multi-Cancer Detection Blood Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Multi-Cancer Detection Blood Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Multi-Cancer Detection Blood Test by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Multi-Cancer Detection Blood Test by Type (2020-2031)
 Figure 55. Global Multi-Cancer Detection Blood Test Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Multi-Cancer Detection Blood Test by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Multi-Cancer Detection Blood Test by Application (2020-2031)
 Figure 58. Global Multi-Cancer Detection Blood Test Price (US$/Unit) by Application (2020-2031)
 Figure 59. Multi-Cancer Detection Blood Test Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network